Perrigo (NYSE: PRGO) gained after Teva Pharma (NYSE: TEVA) withdrew its proposal to ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Mergers and Acquisitions Trader Talk

Canaccord Genuity Raises Price Target on Teva Pharma (TEVA) Following Announced Acquisition of Allergan Generics July 28, 2015 9:23 AM Canaccord Genuity Raises Price Target on Allergan (AGN) Following Announced Generics Sale July 28, 2015 9:13 AM Leerink Partners Raised Price Target on Allergan (AGN) to $388 Following TEVA Announcement July 28, 2015 8:19 AM Leerink Partners Raises Price Target to $84 on Teva Pharma (TEVA) Following Call with CFO July 28, 2015 8:12 AM Teva Pharma (TEVA) PT Raised to $74 at Maxim Group on Deal for Allergan's Generic Drug BusinessJuly 27, 2015 11:10 AM Mylan (MYL) Comments on Teva/Allergan Deal; Strategic Focus Remains UnchangedJuly 27, 2015 6:43 AM Teva Pharma (TEVA) to Acquire Allergan Genetics (AGN) in $40.5B Cash and Stock DealJuly 27, 2015 6:03 AM Allergan Accelerates Transformation to Branded Growth Pharma Leader by Divesting Global Generics Business to Teva for $40.5 BillionJuly 27, 2015 4:37 AM